Healthy people test new drug MF-300 for safety
Knowledge-focused
Completed
This early-stage study tested the safety of a new drug called MF-300 in 100 healthy adults. Participants received either a single dose or multiple doses to see how the drug moves through the body and what side effects occur. The goal was to gather safety information, not to treat…
Phase: PHASE1 • Sponsor: Epirium Bio Inc. • Aim: Knowledge-focused
Last updated Jun 16, 2026 12:49 UTC